Skip to main content
Signal8

Yen Yun

SEC insider (Form 3/4/5 filer). CIK 0001684584. Director at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2025. Located in PASADENA, CA.

Companies Yen Yun has filed insider reports for

  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT): Director
Yen Yun profile photo

Yen Yun

CIK: 0001684584

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LIXTE BIOTECHNOLOGY HOLDINGS, INC. logo
LIXT

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. logo
    LIXT

    LIXTE BIOTECHNOLOGY HOLDINGS, INC.

    Jun 30, 2025
    Award

    Options to Purchase Common Stock

    Direct
    10K shares-
  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. logo
    LIXT

    LIXTE BIOTECHNOLOGY HOLDINGS, INC.

    Jun 30, 2025
    Award

    Options to Purchase Common Stock

    Direct
    11.6K shares-
  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. logo
    LIXT

    LIXTE BIOTECHNOLOGY HOLDINGS, INC.

    Mar 31, 2025
    Award

    Options to Purchase Common Stock

    Direct
    8.8K shares-
  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. logo
    LIXT

    LIXTE BIOTECHNOLOGY HOLDINGS, INC.

    Jan 20, 2025
    Award

    Options to Purchase Common Stock

    Direct
    4.5K shares-
  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. logo
    LIXT

    LIXTE BIOTECHNOLOGY HOLDINGS, INC.

    Sep 30, 2024
    Award

    Options to Purchase Common Stock

    Direct
    5.8K shares-

1-5 of 5